Jackson Acquisition Company II is a blank check company formed in 2024 to enter into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. The company intends to focus its search on targets within the healthcare services, healthcare technology, or broader healthcare industry, utilizing proceeds from its initial public offering and private placement to fund the transaction. It has not yet selected a target business and currently has no revenue, relying on securities sales and sponsor loans for operations. The company’s strategy involves identifying acquisition candidates with strong management teams, growth potential, and clear value propositions that can benefit from access to public capital markets. Management leverages extensive experience in healthcare operations, strategic transactions, and capital markets to drive operational improvements and value creation. The company may pursue targets in any industry or geographic location but prioritizes sectors where its team has deep expertise and networks.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Shell Companies Homepage —
Sector Financial Services IR page —
Tags
special purpose acquisition company, healthcare services, healthcare technology, business combination, blank check company
Press page —

Metrics

Valuation  
Market cap $ 320.46M
Market cap (USD) $ 320.46M
P/E 39.23
PEG —
P/BV -829.23
P/S —
P/OCF —
P/FCF -749.46
Dividend yield —
Turnover / mcap —
Returns  
ROE 1,804.0%
ROI 2,176.7%
ROIC -101.9%
Profit margin —
Growth  
Revenue growing —
Profits growing —
Revenue up 3y —
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding —
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 4
Quality score -10.0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024
Assets 243.176M 234.006M
Net profit 9.116M —
Free cash flow -427.59K —

Figure FY 2025 FY 2024
Share price 10.42 —
P/FCF -721.08 —

Filed figures

Figure Dec 2024 Dec 2025
Balance sheet detail
Cash and deposits (USD) 949,366 521,776
Cash flow detail
Operating cash flow (USD) — -427,590
Change in payables (cash effect) (USD) — -65,230
Reported Mar 18, 2025 Mar 20, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

New York, February 10, 2026 — Jackson Acquisition Company II (the “Company”) announced today that it had received written notice on February 6, 2026 (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the Company is not in compliance with Section 802.01B of the NYSE Listed Company Manual (the “Listing Rule”) which requires the Company to maintain a minimum of 300 public stockholders on a continuous basis. In accordance with applicable NYSE procedures, the Company has 45 days from receipt of the Notice to submit a plan that would bring it into compliance with the minimum stockholder requirement within 18 months of receipt of the Notice.

The Company plans to promptly submit a business plan that demonstrates how the Company expects to return to compliance with the Listing Rule within 18 months of receipt of the Notice.

The Notice has no immediate impact on the Company’s securities, and provided the NYSE approves the plan, the Company’s securities will continue to be listed and traded on the NYSE during the 18-month cure period under their existing ticker symbols.

Prompts

Jackson Acquisition Company II (ticker JACS), listed in United States.

ETFs Holding Jackson Acquisition Company II

ETF Weight in ETF Shares Market value As of
SPAQ 2.53% 69,576 $ 255.426K Jun 30, 2026

Securities

Ticker Type Class Market Exchange Last price Price date
JACS canonical Common share — US nyse 10.83 USD 2026-09-30
JACS-R Right — US nyse 0.04 USD 2026-09-30
JACS-U Unit — US nyse 10.96 USD 2026-09-30